

The Russian Ministry of Health has canceled registration certificates for six drugs, based on requests from the authorized legal entities. Three of the drugs are produced by JSC Khimfarm: Akrimex (ethylmethylhydroxypyridine succinate), Imipenem/Cilastatin (imipenem + cilastatin), and Neuropol (citicoline). The list also includes Andante (zolpidem) for insomnia by Gedeon Richter, Cosentyx (secukinumab) for plaque psoriasis by Novartis, and “Cough Tablets” (sodium bicarbonate + thermopsis herb) by Russian company Pharmapol-Volga, with registration held by Alvils LLC.
Source: GxP News, 20.03.2025, “MINISTRY CANCELS REGISTRATIONS FOR 6 DRUGS”
We use cookies to analyze events on our website, which allows us to improve the site's performance. If you do not want your data to be processed, please disable cookies in your browser settings. By continuing to use our site, you accept its terms of use and give your consent to the processing of cookies. For more detailed information on the use of cookies and how to opt out, please refer to our Cookie Policy.